Bayer Aktiengesellschaft (ETR:BAYN) Shares Up 0.7% – Here’s Why

Bayer Aktiengesellschaft (ETR:BAYN) rose 0.7% during mid-day trading on Wednesday. The stock traded as high as €44.86 and last traded at €44.15. 1,860,703 shares traded hands during trading, The stock had previously closed at €43.83.

Bayer Aktiengesellschaft Stock Down 1.5%

The company has a debt-to-equity ratio of 129.90, a current ratio of 1.04 and a quick ratio of 0.72. The firm has a market capitalization of $44.84 billion, a price-to-earnings ratio of -50.95, a P/E/G ratio of 36.39 and a beta of 0.84. The stock has a fifty day moving average of €47.97 and a two-hundred day moving average of €43.81.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.